Atrial Fibrillation Market Research Report – Forecast to 2027

Atrial Fibrillation Market Research Report: By Type (Paroxysmal and Others), by Treatment (Medications, Non-Surgical Procedures, and Surgical Procedures), by End-User (Hospitals, Electrophysiology Labs, and Ambulatory Surgical Centers)—Forecast till 2027

ID: MRFR/HC/5058-HCR | February, 2021 | Region : Global

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Atrial Fibrillation Market, by Type

6.1 Introduction

6.2 Paroxysmal Atrial Fibrillation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Persistent Atrial Fibrillation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Permanent Atrial Fibrillation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Atrial Fibrillation Market, by Treatment

7.1 Introduction

7.2 Medications

7.2.1 Blood Thinners

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2 Rate controllers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3 Rhythm controllers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Non-surgical procedures

7.3.1 Catheter ablation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2 Electrical cardioversion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Surgical procedures

7.4.1 Pacemaker implantation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.2 Open-heart maze procedure

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Atrial Fibrillation Market, by End-User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Electrophysiology Labs

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Atrial Fibrillation Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Johnson & Johnson Services, Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Abbott

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Medtronic Plc

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Boston Scientific Corporation

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 MicroPort Scientific Corporation

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Biotronik SE & Co. KG

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Koninklijke Philips N.V.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 AtriCure, Inc.

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 CardioFocus

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Osypka AG

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Siemens AG

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Biosense Webster, Inc.

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 CathRx Ltd.

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Vanguard AG

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Atrial Fibrillation Industry

Chapter 13. Appendix


LIST OF TABLES

Table 1 Global Atrial Fibrillation Market Synopsis, 2020–2027

Table 2 Global Atrial Fibrillation Market Estimates and Forecast, 2020-2027(USD Million)

Table 3 Global Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 4 Global Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 5 Global Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 6 Global Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 7 North America: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 8 North America: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 9 North America: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 10 North America: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 11 US: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 12 US: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 13 US: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 14 US: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 15 Canada: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 16 Canada: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 17 Canada: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 18 Canada: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 19 South America: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 20 South America: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 21 South America: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 22 South America: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 23 Europe: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 24 Europe: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 25 Europe: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 26 Europe: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 27 Western Europe: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 28 Western Europe: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 29 Western Europe: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 30 Western Europe: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 31 Eastern Europe: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 32 Eastern Europe: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 33 Eastern Europe: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 34 Eastern Europe: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 35 Asia-Pacific: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 36 Asia-Pacific: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 37 Asia-Pacific: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 38 Asia-Pacific: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

Table 39 Middle East & Africa: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)

Table 40 Middle East & Africa: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)

Table 41 Middle East & Africa: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)

Table 42 Middle East & Africa: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)

LIST OF FIGURES


Figure 1 Research Process

Figure 2 Segmentation for Global Atrial Fibrillation Market

Figure 3 Segmentation Market Dynamics for Global Atrial Fibrillation Market

Figure 4 Global Atrial Fibrillation Market Share, by Type, 2020 (%)

Figure 5 Global Atrial Fibrillation Market Share, by Treatment, 2020 (%)

Figure 6 Global Atrial Fibrillation Market Share, by End-User, 2020 (%)

Figure 7 Global Atrial Fibrillation Market Share, by Region, 2020 (%)

Figure 8 North America: Atrial Fibrillation Market Share, by Country, 2020 (%)

Figure 9 Europe: Atrial Fibrillation Market Share, by Country, 2020 (%)

Figure 10 Asia-Pacific: Atrial Fibrillation Market Share, by Country, 2020 (%)

Figure 11 Middle East & Africa: Atrial Fibrillation Market Share, by Country, 2020 (%)

Figure 12 Global Atrial Fibrillation Market: Company Share Analysis, 2020 (%)

Figure 13 Johnson & Johnson Services, Inc.: Key Financials

Figure 14 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 15 Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 16 Abbott: Key Financials

Figure 17 Abbott: Segmental Revenue

Figure 18 Abbott: Geographical Revenue

Figure 19 Medtronic Plc: Key Financials

Figure 20 Medtronic Plc: Segmental Revenue

Figure 21 Medtronic Plc: Geographical Revenue

Figure 22 Boston Scientific Corporation: Key Financials

Figure 23 Boston Scientific Corporation: Segmental Revenue

Figure 24 Boston Scientific Corporation: Geographical Revenue

Figure 25 MicroPort Scientific Corporation: Key Financials

Figure 26 MicroPort Scientific Corporation: Segmental Revenue

Figure 27 MicroPort Scientific Corporation: Geographical Revenue

Figure 28 Biotronik SE & Co. KG: Key Financials

Figure 29 Biotronik SE & Co. KG: Segmental Revenue

Figure 30 Biotronik SE & Co. KG: Geographical Revenue

Figure 31 Koninklijke Philips N.V.: Key Financials

Figure 32 Koninklijke Philips N.V.: Segmental Revenue

Figure 33 Koninklijke Philips N.V.: Geographical Revenue

Figure 34 AtriCure, Inc.: Key Financials

Figure 35 AtriCure, Inc.: Segmental Revenue

Figure 36 AtriCure, Inc.: Geographical Revenue

Figure 37 CardioFocus: Key Financials

Figure 38 CardioFocus: Segmental Revenue

Figure 39 CardioFocus: Geographical Revenue

Figure 40 Osypka AG: Key Financials

Figure 41 Osypka AG: Segmental Revenue

Figure 42 Osypka AG: Geographical Revenue

Figure 43 Siemens AG: Key Financials

Figure 44 Siemens AG: Segmental Revenue

Figure 45 Siemens AG: Geographical Revenue

Figure 46 Biosense Webster, Inc.: Key Financials

Figure 47 Biosense Webster, Inc.: Segmental Revenue

Figure 48 Biosense Webster, Inc.: Geographical Revenue

Figure 49 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.: Key Financials

Figure 50 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.: Segmental Revenue

Figure 51 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.: Geographical Revenue

Figure 52 CathRx Ltd.: Key Financials

Figure 53 CathRx Ltd.: Segmental Revenue

Figure 54 CathRx Ltd.: Geographical Revenue

Figure 55 Vanguard AG: Key Financials

Figure 56 Vanguard AG: Segmental Revenue

Figure 57 Vanguard AG: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Atrial Fibrillation Systems Market